News
-
-
-
-
-
PRESS RELEASE
Relief Therapeutics Completes Strategic Transition with Sale of GOLIKE Rights ex-US
Relief Therapeutics completes strategic transition by selling GOLIKE rights outside the U.S. to Nutrisens, focusing on R&D and licensing for commercialized products. Company receives CHF 1.2 million upfront -
PRESS RELEASE
Preliminary results 2024: SBO with strong cash generation and solid results despite challenging market conditions
Schoeller-Bleckmann Oilfield Equipment AG reports strong cash generation and solid results for 2024 despite challenging market conditions. Preliminary results show resilient performance -
-
PRESS RELEASE
Press Release: Sarclisa approved in the EU as the first anti-CD38 therapy in combination with standard-of-care VRd to treat transplant-ineligible newly diagnosed multiple myeloma
EU approves Sarclisa as first anti-CD38 therapy in combination with VRd for transplant-ineligible NDMM based on positive IMROZ study results. Third indication for Sarclisa in the EU -
-